Felix Pharmaceuticals Private Limited

Pharmaceutical company specializing in manufacturing, importing, and exporting drugs and formulations.

2006 | Kolkata, West Bengal (India) | Merged
Last Updated: January 18, 2025

Felix Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.40 M
  • Company Age 19 Year, 2 Days
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth -1.65%
  • Profit Growth 351.01%
  • Ebitda 75.07%
  • Net Worth 3.64%
  • Total Assets 2.90%

About Felix Pharmaceuticals

Felix Pharmaceuticals Private Limited (FPPL) is Amalgamated company established on 06 Feb 2006 with its office registered at Kolkata, West Bengal, India and has been running since 19 Year, 2 Days with a paid up capital of 0.40 M. According to MCA records, 2 Directors are linked to this company as of 18 Jan 2025.

Company Details

  • Location

    Kolkata, West Bengal, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24231WB2006PTC256797

  • Company No.

    049035

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    06 Feb 2006

  • Date of AGM

    24 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kolkata

Industry

Pharma

Who are the key members and board of directors at Felix Pharmaceuticals?

Board Members (2)

Name Designation Appointment Date Status
Padmanabh Bhagat Country flag representing In Director 06-May-2017 Current
Satyabodh Bhagat Country flag representing In Director 06-May-2017 Current

Financial Performance of Felix Pharmaceuticals.

Felix Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.65% decrease. The company also saw a substantial improvement in profitability, with a 351.01% increase in profit. The company's net worth moved up by a moderate rise of 3.64%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-1.65%
Revenue from Operations
Total Assets
2.90%
Profit or Loss
351.01%
Net Worth
3.64%
EBITDA
75.07%

What is the Ownership and Shareholding Structure of Felix Pharmaceuticals?

In 2022, Felix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Felix Pharmaceuticals?

Unlock and access historical data on people associated with Felix Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Felix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Felix Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Felix Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Felix Pharmaceuticals Private Limited last Annual general meeting of members was held on 24 Sep 2022 as per latest MCA records.

    24 Sep 2022

  • Balance Sheet

    Felix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kolkata.

    31 Mar 2022

  • Director Appointment

    Padmanabh Bhagat was appointed as a Director was appointed as a Director on 06 May 2017 & has been associated with this company since 7 years 9 months .

    06 May 2017

  • Director Appointment

    Satyabodh Bhagat was appointed as a Director was appointed as a Director on 06 May 2017 & has been associated with this company since 7 years 9 months .

    06 May 2017

  • Company Incorporation

    Felix Pharmaceuticals Private Limited was registered on 06 Feb 2006 with Roc Kolkata & aged 19 years 2 days as per MCA records.

    06 Feb 2006

Frequently asked questions

  • Felix Pharmaceuticals Private Limited was incorporated on 06 Feb 2006.

  • The authorized share capital of Felix Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.40 M.

  • Currently 2 directors are associated with Felix Pharmaceuticals Private Limited.

    • Padmanabh Bhagat
    • Satyabodh Bhagat
  • As per Ministry of Corporate Affairs (Mca), the registered address of Felix Pharmaceuticals Private Limited is 53A Tiljala Road Mescab Center, 4Th Floor India, Kolkata, West Bengal, 700046.

  • The corporate identification number (CIN) of Felix Pharmaceuticals Private Limited is U24231WB2006PTC256797 and the company number is 049035 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Felix Pharmaceuticals Private Limited is https://www.felixpharma.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Felix Pharmaceuticals Private Limited has fallen by -1.65%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Felix Pharmaceuticals Private Limited has experienced an upsurge of 3.64%.

  • The most recent Balance Sheet for Felix Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.

Similar Companies Based on Drug Formulation & Development